DnB Asset Management AS

SEC CIK: 0001456670
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

CHRS holding history

Coherus Oncology, Inc. in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CHRS overview All 13F holders of CHRS Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of CHRS by DnB Asset Management AS, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−18,290−100.0%	Sold out	Holders
Q3 2021	18,290	$293.9K	<0.1%	−4,363−19.3%	Reduced	Holders
Q2 2021	22,653	$313.3K	<0.1%	+2,368+11.7%	Added	Holders
Q1 2021	20,285	$296.4K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.